Our approach used to identify secretory proteins showed a significant differential expression of apoA1 and SAP in lung cancer patients and normal healthy tissue donors, which might be useful when utilizing these proteins as blood serum biomarkers for lung cancer. This evidence concerns the gene APOA1 and lung carcinoma.